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Introduction Vesicoureteral reflux (VUR) is one of the most common ailments in children. Evidence-based 
guidelines recommend conservative treatment in children with VUR, followed by endoscopic surgery in 
those with breakthrough febrile urinary tract infections (UTIs). Despite this fact, the management of VUR 
is still controversial. Our objective is to evaluate the conservative strategy in children with primary VUR in 
terms of renal function and scarring, and identify factors associated with poor prognosis in those children.
Material and methods A retrospective study was carried out in a tertiary center in children with primary 
VUR under conservative strategy treatment from 1989 to 2015. Data extracted included age of presenta-
tion, family and prenatal backgrounds, radiographic evaluation including ultrasound (US), dimercaptosuc-
cinic acid (DMSA) scans and voiding cystourethrogram (VCUG). The SPSS program was used for statistical 
analysis.
Results Two-hundred and five patients were diagnosed and followed a conservative therapy scheme 
(49.8% males, 50.2% females) after febrile UTI (73.17%) or prenatal diagnosis (26.83%). VCUG showed 
53.20% of low-moderate VUR grade, 46.80% high VUR grade. Renal damage was present at diagnosis 
in 40.89%. Mean follow-up reakthrough recurrent febrile UTIs and underwent surgery. Conservative 
therapy was followed in 189 patients. Renal scarring or decreased kidney function were shown in 
15.12% respectively. Renal damage was identified as a risk factor for poor prognosis (p-value <0.005) 
only for renal function deterioration. Patients with high-grade VUR required surgery in a significantly 
greater proportion (p <0.005) due to recurrent febrile UTIs.
Conclusions Conservative strategy is a feasible treatment for primary VUR in children. The majority of 
cases could be managed conservatively with good outcomes after long-term follow-up. Decreased renal 
function is more frequent in patients with high-grade VUR. Renal damage at diagnosis increases the risk 
for surgical treatment.
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iNtrOdUctiON
Vesicoureteral reflux (VUR) is a heterogeneous ail-
ment defined by the retrograde ascension of urine 
from the bladder to the urethra, in the absence 
of any anatomic abnormality or neurologic condi-
Citation: Alvarez N, Delgado Alvira R, Gonzalez Ruiz Y, et al. Predicting long-term renal damage in children with VUR under conservative initial management:  
205 cases in a tertiary referral center. Cent European J Urol. 2018; 71: 142-147.
tion [1]. VUR is known to increase the risk of uri-
nary tract infections (UTIs) and permanent renal 
damage. Traditionally, high-grade VUR is associ-
ated with a greater risk of febrile UTIs and sever-
ity of renal damage. Bilateral renal injury has also 
been related to hypertension and chronic renal 
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insufficiency [2]. On the other hand, VUR tends 
to disappear spontaneously during childhood, and 
in those children without UTIs, renal damage is un-
common. Currently, there is still a lack of consensus 
about the optimal treatment for primary VUR in or-
der to prevent renal injury progression [3] and sev-
eral strategies have been described with a huge vari-
ability between surgeons and paediatricians treating 
these patients. Classically, primary VUR treatment 
is based on two different pillars: surgical correction 
techniques or conservative treatment formed by hy-
gienic habits recommendations and continuous an-
tibiotic prophylaxis (CAP), looking forward to spon-
taneous resolution. The majority of evidence-based 
guidelines and consensus documents recommend 
the conservative strategy as the first-line therapy 
in all children with VUR, leaving surgery for those 
patients with breakthrough recurrent UTIs during 
follow-up [3, 4]. Several studies have demonstrated 
the lack of benefits in renal function in those pa-
tients who undergo surgery at diagnosis, in terms 
of appearance and progression of renal scars, hy-
pertension or renal insufficiency [5]. Our objective 
was to identify prognostic factors in children under 
conservative initial treatment in terms of long-term 
renal function and damage outcomes, as well as to 
predict the need for surgical intervention, among the 
patients treated in a tertiary referral center during 
the last 25 years.
MateriaL aNd MetHOdS
A retrospective cohort study was carried out in pa-
tients between 0 and 15 years old, diagnosed with 
primary reflux after an urinary tract infection 
or prenatal ultrasound findings between 1989 and 
2015 who underwent the non-operative strategy af-
ter diagnosis. Children with concomitant nephron-
urologic diseases were excluded. Data included age 
of presentation, family and prenatal backgrounds, 
Figure 1. Current evidence-based guidelines standard algorithm for vesicoureteral reflux management in children. 
The figure has been created based on a figure published in the Spanish National Guidelines for VUR (source [4]).
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mean follow-up period was 115 months (107–124). 
Among the 205 patients included in the study, con-
trol DMSA scan were performed in 172, showing re-
nal function deterioration and renal scarring wors-
ening in 15.12% of patients, respectively (n = 26). 
Fifty-two patients had suffered at least one UTI, but 
only 16 presented with recurrent episodes. The per-
centage of patients with high-grade VUR who under-
went surgery was higher (81.25%) than those with 
low-intermediate graede VUR (18.75%) (OR = 5.60, 
IC 95% 1.54–0.31). Among the potential renal dam-
age risk factors analyzed, we have only found sta-
tistically significant differences in renal damage at 
diagnosis (p = 0.005 χ2 Pearson test) for renal func-
tion worsening (Table 1). In relation to renal scar-
ring worsening, the risk factors analyzed did not 
show statistically significant differences (Table 2). 
Age of diagnosis in patients diagnosed after febrile 
UTIs has not been identified as a risk factor for nei-
ther decrease in renal function (p = 0.142, Mann-
Whitney test) nor scarring (p = 0.0117, Mann-Whit-
ney test) In terms of risk factors for surgery, among 
the 205 patients who followed the initial non-oper-
ative treatment scheme, 16 underwent surgery be-
cause of recurrent febrile UTIs. In those patients, 
risk factor analysis showed statistical difference only 
in patients with high-grade VUR (IV-V) at diagnosis 
(p = 0.009, OR = 5.6 IC 95%) (Table 3). Age of diag-
nosis was not identified as a risk factor (p = 0.223, 
Mann-Whitney test) for requiring surgery in those 
patients diagnosed after a febrile UTI.
diScUSSiON
Primary VUR is a classical common topic for debate 
between paediatricians and paediatric urological 
radiographic evaluation including ultrasounds (US), 
dimercaptosuccinic acid (DMSA) scans and voiding 
cystourethrograms (VCUG), extracted from elec-
tronic medical records. All patients were diagnosed 
with VCUG and classified using the International 
VUR Classification [6]. Renal damage was evaluated 
with DMSA scan and classified using the Goldraich 
Classification [7, 8]. Febrile UTIs were defined by 
the presence of fever, alterations in urinary sedi-
ment and confirmation by urine culture. Conserva-
tive strategy includes clinical observation, hygienie 
habits recommendations and CAP, indicating sur-
gery in those with breakthrough febrile UTIs follow-
ing an evidence-based algorithm (Figure 1). Analysis 
of poor prognostic factors was based on current lit-
erature and included gender, type of diagnosis, age 
of first UTI, VUR grade, bilaterality, renal damage 
at diagnosis and voiding dysfunction. All statistical 
analysis was performed using SPSS v.18.0.
reSULtS 
A total of 297 patients were diagnosed with primary 
VUR from 1989 to 2015. Of these, 205 patients were 
managed with conservative treatment and were in-
cluded in the study. Epidemiological variables were: 
49.8% males and 50.2% females were included, with a 
mean age at diagnosis of 21.71 months (0–144). Clini-
cal variables were: primary VUR was diagnosed after 
a febrile UTI in 73.17% of children and 26.83% with 
prenatal ultrasound diagnosis of hydronephrosis. First 
VCUG showed 53.2% of low-moderate grade VUR 
(I–III grades) and 46.80% presented high-grade VUR 
(IV–V grades). Bilateral reflux was present in 46.83% 
of children. Renal damage at diagnosis was present 
in 40.89% of patients. During the clinical course, 
Table 1. Risk factors for renal function worsening in children with primary vesicoureteral reflux under conservative treatment
Risk factors RF Stable (n) RF Worsening (n) p-value
Gender MaleFemale
66
80
14
11 p = 0.336
Diagnosis UTIs
Prenatal US
114
32
18
8
p = 0.464
VUR Grade
I–III
IV–V
78
68
9
17
p = 0.120
Bilateral VUR
Yes
No
65
81
15
11 p = 0.304
Voiding Dysfunction
Yes
No
26
120
8
18
p = 0.207
Renal damage at diagnosis YesNo
55
91
18
8
p = 0.005
Total patients 146 26
RF – renal function; UTIs – urinary tract infections; US – ultrasound; VUR – vesicoureteral reflux
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been observed in 15.12% of our sample group. Com-
paring our results to current literature, our rates 
are very similar to those published by the RIVUR 
study [9, 10, 11] in which 11.9% of patients under 
prophylaxis and 10.2% with placebo showed progres-
sion of renal scarring. Systematic reviews performed 
by Nagler et al. [5] and Wheeler et al. [12] compar-
ing conservative treatment to surgery include three 
studies – IRS EUR [13], IRS USA [14] and Smellie 
2001 [15] – where renal scarring was evaluated af-
ter 5 years of follow-up. The 43.3% of patients oper-
ated and the 41.39% with CAP showed progression 
of renal damage (RR 1.05, 0.95–1.29). Attending 
to a comparative period of follow-up with our co-
hort, the IRS EUR 1981–2003 study [16] performs 
the evaluation after 10 years but the outcomes only 
include the appearance of new renal scars and their 
surgeons. Despite the high incidence of this ailment 
and the increasing number of publications about 
its management, there is still a high variability in 
opinions among professionals. The majority of the 
evidence-based guidelines promote a non-operative 
therapy for primary VUR in children. In our country, 
the first National Guideline was published in 2008 
[4] in order to improve clinical practice. Those rec-
ommendations included not only algorithms for the 
diagnosis and management of those children, but 
also indications for non-invasive follow-up avoid-
ing unnecessary complementary testing in asymp-
tomatic children, which should be performed every 
2 or 3 years. Because of that, we have not performed 
DMSA-control nor VCUG-control tests in all pa-
tients, only in 172 of 205 patients. Both renal func-
tion decrease and worsening of renal scarring have 
Table 2. Risk factors for renal scarring Worsening in children with primary vesicoureteral reflux under conservative treatment
Table 3. Prognostic factors for surgery in children with primary vesicoureteral reflux under conservative treatment
Risk factors RF Stable (n) RF Worsening (n) p-value
Sex MaleFemale
68
78
13
13 p = 0.913
Diagnosis UTIs
Prenatal US
113
32
19
7
p = 0.819
VUR Grade
I–III
IV–V
77
10
10
16
p = 0.259
Bilateral VUR
Yes
No
82
64
10
16
p = 0.304
Voiding Dysfunction
Yes
No
27
119
7
19
p = 0.207
Renal damage at diagnosis YesNo
59
87
14
12 p = 0.005
Total patients 146 26
RS – renal scarring; UTIs – urinary tract infections; US – ultrasound; VUR – vesicoureteral reflux
Risk factors No Surgery (n) Surgery (n) p-value
Sex MaleFemale
93
96
6
10
p = 0.523
Diagnosis UTIs
Prenatal US
137
52
13
3 p = 0.566
VUR Grade
I–III
IV–V
105
82
3
13 p = 0.009
Bilateral VUR
Yes
No
85
104
11
5
p = 0.117
Voiding Dysfunction
Yes
No
29
160
5
11 p = 0.151
Renal damage at diagnosis YesNo
73
114
10
6
p = 0.117
Total patients 189 16
UTIs – urinary tract infections; US – ultrasound; VUR – vesicoureteral reflux
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results are not feasible for comparison with ours. 
The high percentage of patients with renal injury 
progression is noticeable in these studies, as well 
as similar rates in our cohort to the RIVUR study. 
These results should be taken with caution, as mul-
tiple epidemiological and clinical variables make 
VUR cohorts very heterogeneous, hindering the ex-
trapolation of results. Despite this fact, we consider 
the non-operative therapy a feasible treatment for 
all children with VUR. In our cohort, the majority 
of patients were managed conservatively and our 
results are comparable to other strategies already 
published. In relation to the analysis of risk factors, 
renal function worsening is associated with the re-
nal damage at diagnosis. This association has al-
ready been reported by several authors [2, 17, 18]. 
Currently, some authors consider congenital VUR 
a different entity from the diagnosis of reflux af-
ter a febrile UTI, as congenital hydronephrosis 
due to vesicoureteral reflux is usually accompanied 
by a variable degree of renal dysplasia, which is con-
sidered an independent factor for renal injury pro-
gression itself, in absence of pyelonephritis [19]. Risk 
factors for surgical treatment are in direct relation-
ship to recurrent febrile UTIs as shown in the non-
operative management algorithm (Figure 1). A small 
proportion of children under conservative treatment 
presented with recurrent UTI episodes. According 
to our data, 52 children suffered isolated episodes 
of febrile UTIs, but only 16 presented with recur-
rent infections which led to the indication of surgery. 
The percentage of patients with high-grade VUR 
who underwent surgery was higher (81.25%) than 
those with low-intermediate grade VUR (18.75%) 
(OR = 5.60, IC 95% 1.54–20.31). The relation be-
tween VUR grades and recurrent UTIs has been 
widely reported in the literature [17, 20–24]. Hertz 
et al. [25] did not find this association in patients 
with congenital renal damage. Despite this finding, 
we would like to highlight that the majority of chil-
dren with VUR followed a conservative treatment, 
despite their initial VUR grade, renal damage, gen-
der, age or type of VUR. These results should be tak-
en into account, as surgery persists as the elective 
therapy for some colleagues even though surgical 
treatment has not demonstrated any benefit in this 
group of patients. Our study supports the evidence-
based recommendations and could help to stamp out 
the stigma of VUR as a primarily surgical disease.
cONcLUSiONS
The presence of renal damage at diagnosis is con-
sidered an independent risk factor for poor renal 
function prognosis. Patients with high-grade VUR 
are most at risk of surgery, despite the minority 
of patients requiring surgical treatment during 
follow-up. Conservative initial therapy for prima-
ry VUR in children shows similar results in terms 
of renal function progression and worsening of scar-
ring to other strategies reported in the literature. 
Evidence-based algorithms should be promoted 
in order to avoid unnecessary aggressive therapies 
in these children. VUR should not be considered 
a surgical entity any longer.
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